91 related articles for article (PubMed ID: 22325844)
1. Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.
Bliven-Sizemore EE; Johnson JL; Goldberg S; Burman WJ; Villarino ME; Chaisson RE;
Int J Tuberc Lung Dis; 2012 Apr; 16(4):473-9. PubMed ID: 22325844
[TBL] [Abstract][Full Text] [Related]
2. Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.
Kumar A; Kumar AM; Gupta D; Kanchar A; Mohammed S; Srinath S; Tripathy S; Rajasekaran S; Chan PL; Swaminathan S; Dewan PK
Int J Tuberc Lung Dis; 2012 May; 16(5):573-8. PubMed ID: 22507931
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
5. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
6. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
7. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
[TBL] [Abstract][Full Text] [Related]
8. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
10. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.
Lawn SD; Ayles H; Egwaga S; Williams B; Mukadi YD; Santos Filho ED; Godfrey-Faussett P; Granich RM; Harries AD
Int J Tuberc Lung Dis; 2011 Mar; 15(3):287-95. PubMed ID: 21333094
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of anti-tuberculosis treatment and HIV serostatus.
Lanternier F; Dalban C; Perez L; Bricaire F; Costagliola D; Caumes E
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1203-9. PubMed ID: 17958982
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi.
Bong CN; Chen SC; Jong YJ; Tok TS; Hsu CF; Schouten EJ; Makombe SD; Yu JK; Harries AD
Int J Tuberc Lung Dis; 2007 May; 11(5):534-8. PubMed ID: 17439677
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
14. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival.
Wiseman CA; Schaaf HS; Cotton MF; Gie RP; Jennings T; Whitelaw A; Roux P; Hesseling AC
Int J Tuberc Lung Dis; 2011 Jun; 15(6):770-5. PubMed ID: 21575297
[TBL] [Abstract][Full Text] [Related]
15. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.
Kwange SO; Budambula NL
Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study.
Vashishtha R; Mohan K; Singh B; Devarapu SK; Sreenivas V; Ranjan S; Gupta D; Sinha S; Sharma SK
BMC Infect Dis; 2013 Oct; 13():468. PubMed ID: 24099345
[TBL] [Abstract][Full Text] [Related]
18. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Vibhagool A
J Infect; 2006 Mar; 52(3):188-94. PubMed ID: 15992932
[TBL] [Abstract][Full Text] [Related]
19. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
[TBL] [Abstract][Full Text] [Related]
20. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]